Sankala Group LLC

SEC CIK: 0002113426
Latest filing: Aug 18, 2026

SEC filings (opens in a new tab)

NVO holding history

Novo Nordisk A S in every 13F filed by Sankala Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overview All 13F holders of NVO Full Q2 2026 holdings

Shares (Q2 2026): 12,306
Value: $564.1K
% of portfolio: 0.4%
Quarters held: 3; Since Q4 2025

Holdings of NVO by Sankala Group LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	12,306	$564.1K	0.4%	+1,874+18.0%	Added	Holders
Q1 2026	10,432	$378.3K	0.3%	+281+2.8%	Added	Holders
Q4 2025	10,151	$380.2K	0.3%	–	No prior filing	Holders